Pharmasyntez has a total of 125 patents globally, out of which 61 have been granted. Of these 125 patents, more than 72% patents are active. Australia is where Pharmasyntez has filed the maximum number of patents, followed by Russia and United States of America. Parallelly, Russia seems to be the main focused R&D centre and also is the origin country of Pharmasyntez.
Pharmasyntez was founded in 1997. Pharmasyntez is a pharmaceutical company specializing in the development and distribution of cost-effective medications for tuberculosis, HIV, cancer treatment, and blood disorders.
Do read about some of the most popular patents of Pharmasyntez which have been covered by us in this article and also you can find Pharmasyntez patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Pharmasyntez patent portfolio.
How many patents does Pharmasyntez have?
Pharmasyntez has a total of 125 patents globally. These patents belong to 23 unique patent families. Out of 125 patents, 91 patents are active.
How Many Patents did Pharmasyntez File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Pharmasyntez Applications Filed | Pharmasyntez Patents Granted |
| 2024 | 1 | – |
| 2023 | – | 3 |
| 2022 | 10 | 3 |
| 2021 | 17 | 2 |
| 2020 | 2 | 9 |
| 2019 | 4 | 17 |
| 2018 | 1 | 2 |
| 2017 | 1 | 3 |
| 2016 | 2 | 6 |
| 2015 | 3 | 2 |
| 2014 | 1 | 7 |
How many Pharmasyntez patents are Alive/Dead?
Worldwide Patents
How Many Patents did Pharmasyntez File in Different Countries?
Countries in which Pharmasyntez Filed Patents
| Country | Patent |
| Australia | 8 |
| Russia | 7 |
| United States of America | 5 |
| Europe (EPO) | 4 |
| India | 4 |
| Canada | 4 |
| China | 4 |
| Indonesia | 4 |
| Peru | 3 |
| Mongolia | 3 |
| South Africa | 3 |
| Viet Nam | 3 |
| New Zealand | 3 |
| Brazil | 3 |
| Korea (South) | 3 |
| Argentina | 3 |
| Mexico | 3 |
| Japan | 3 |
| Philippines | 2 |
| Colombia | 2 |
| Austria | 2 |
| Albania | 2 |
| Denmark | 2 |
| Chile | 2 |
| Portugal | 2 |
| Israel | 2 |
| Cuba | 2 |
| Poland | 1 |
| Georgia | 1 |
| Singapore | 1 |
| Costa Rica | 1 |
| Germany | 1 |
| Lithuania | 1 |
| Dominican Republic | 1 |
| Malaysia | 1 |
| Slovenia | 1 |
| Malta | 1 |
| Pakistan | 1 |
| Croatia | 1 |
| Hong Kong (S.A.R.) | 1 |
| Spain | 1 |
| Hungary | 1 |
| Tunisia | 1 |
| Serbia | 1 |
| Eurasian Patent Organization | 1 |
| Slovakia | 1 |
| El Salvador | 1 |
| Nicaragua | 1 |
| Norway | 1 |
| Ukraine | 1 |
| Montenegro | 1 |
| Uruguay | 1 |
| Morocco | 1 |
| Cyprus | 1 |
| Jordan | 1 |
Where are Research Centers of Pharmasyntez Patents Located?
What are Pharmasyntez key innovation segments?
What Technologies are Covered by Pharmasyntez?
The chart below distributes patents filed by Pharmasyntez in different countries on the basis of the technology protected in patents. It also represents the markets where Pharmasyntez thinks it’s important to protect particular technology inventions.
R&D Focus: How has Pharmasyntez search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!